| |
|
|
|
Cleveland Biolabs
|
|
3.1035 -0.0865 (-2.7116%) |
10/20/2017 3:55pm |
|
Open: |
3.1764 |
Pre close: |
3.1900 |
Target:
|
3.96
|
|
High: |
3.2164 |
Low: |
3.0700 |
Resistance:
|
3.39
3.69
|
|
Volume: |
41,491 |
Market Cap: |
35.00M |
Support:
|
2.90
2.41
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.18
 |
MACD |
MACD(12,26):
|
0.02 |
|
MA(20): |
3.35 |
Signal(12,26,9): |
0.08 |
|
MA(100): |
3.04 |
Stochastic Oscillator |
%K(14,3):
|
15.76 |
|
MA(250): |
2.44  |
%D(3): |
16.99 |
|
Average Volume(K) |
3-Month: |
6293
|
52-Week |
High:
|
5.55 |
|
10-Days: |
1347 |
Low: |
1.22 |
|
RSI |
RSI(14):
|
43.92 |
Change(%): |
94.0 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.670 |
Return on Equity (ttm) |
-64.3 |
Shares Out. (M) |
0.00 |
|
EPS Est. Current Year |
-0.160 |
Return on Assets (ttm) |
-23.8 |
Shares Float (M) |
3.14 |
|
EPS Est. Next Year |
-0.480 |
PEG Ratio |
0.00 |
% Held by Insiders |
58.27 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
-64.1 |
% Held by Institutions |
4.64 |
|
Forward EPS |
1.#IO |
Gross Profit (p.s.) |
0.312 |
Shares Short (K) |
69 |
|
Book Value (p.s.) |
0.410 |
EBITDA (p.s.) |
-0.506 |
P/E |
-4.63 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
7.57 |
|
Profit Margin |
-253.07 |
Operating Cash Flow
(M) |
-4.99 |
P/S |
134644144.00 |
|
Operating Margin |
-197.09 |
Levered Free Cash Flow
(M) |
-5.34 |
P/CF |
-0.00 |
|
|
|
|
|
|
|
